bioRxiv (Cold Spring Harbor Laboratory) · 2018 · 23 citations · 35 references
Life SciencesGeneticsMolecular BiologyCancer GeneticsDna RepairMolecular OncologyDna DamageDna Double-strand Break RepairDna Strand BreaksDouble-strand Break RepairHomologous RecombinationNon-homologous End JoiningAtm DeficiencyDna Damage Response PathwaysDna Double-strand BreaksDna Topoisomerase I InhibitionDouble-strand Dna BreaksNon-homologous End Joining DefectsTopoisomerase-mediated Dna BreaksTumor Suppressor Gene Mutations
Summary Mutations in the ATM tumor suppressor confer hypersensitivity to DNA-damaging agents. To explore genetic resistance mechanisms, we performed genome-wide CRISPR-Cas9 screens in cells treated with the DNA topoisomerase poison topotecan. Thus, we establish that loss of terminal components of the non-homologous end-joining (NHEJ) machinery or the BRCA1-A complex specifically confers topotecan resistance to ATM-deficient cells. We show that hypersensitivity of ATM-mutant cells to topotecan or the poly-(ADP-ribose) polymerase inhibitor olaparib is due to delayed homologous recombination repair at DNA-replication-fork-associated double-strand breaks (DSBs), resulting in toxic NHEJ-mediated chromosome fusions. Accordingly, restoring legitimate repair in ATM-deficient cells, either by preventing NHEJ DNA ligation or by enhancing DSB-resection by BRCA1-A complex inactivation, markedly suppresses this toxicity. Our work suggests opportunities for patient stratification in ATM-deficient cancers and when using ATM inhibitors in the clinic, and identifies additional therapeutic vulnerabilities that might be exploited when such cancers evolve drug resistance. One Sentence Summary ATM counteracts toxic NHEJ at broken replication forks
35
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence, Petar Stojanov, Craig H. Mermel et al. · Nature · 2014 · 3.2K citations · Full text
Medicine, Bioinformatics, Oncology +16
Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasia
Carrolee Barlow, Shinji Hirotsune, Richard Paylor et al. · Cell · 1996 · 1.5K citations · Full text
Human CtIP promotes DNA end resection
Alessandro A. Sartori, Claudia Lukas, Julia Coates et al. · Nature · 2007 · 1.3K citations · Full text